Dr. Eric Dusseux

CEO at BIONIK Laboratories
On the record
Represented by:
Recent Quotes
Sign up to view all
  • We are thrilled to receive approval from the Ministry of Food and Drug Safety for our InMotion® ARM robotic systems. This entry into the South Korean market is significant for our Company as we continue to seek penetration throughout Asia, where we believe robotic technologies are more readily adopted. To have our distributor Curexo receiving a first purchase order so quickly is equally exciting and showcases the appetite South Korean healthcare facilities have for innovative technologies that can enhance patient outcomes. We look forward to working with SeoSong Hospital to enhance patient care for those recovering from stroke.

    28 May 2020
Employment
Sign up to view all
  • BIONIK Laboratories
    CEO